ATE143810T1 - Hepatozytwachstumsfaktor enthaltende mittel - Google Patents

Hepatozytwachstumsfaktor enthaltende mittel

Info

Publication number
ATE143810T1
ATE143810T1 AT92109374T AT92109374T ATE143810T1 AT E143810 T1 ATE143810 T1 AT E143810T1 AT 92109374 T AT92109374 T AT 92109374T AT 92109374 T AT92109374 T AT 92109374T AT E143810 T1 ATE143810 T1 AT E143810T1
Authority
AT
Austria
Prior art keywords
growth factor
hepatocyt
agents containing
hhgf
hepatocyte
Prior art date
Application number
AT92109374T
Other languages
German (de)
English (en)
Inventor
Daiji Naka
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE143810T1 publication Critical patent/ATE143810T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Materials For Medical Uses (AREA)
AT92109374T 1991-06-03 1992-06-03 Hepatozytwachstumsfaktor enthaltende mittel ATE143810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13127191 1991-06-03
JP3812292 1992-02-25

Publications (1)

Publication Number Publication Date
ATE143810T1 true ATE143810T1 (de) 1996-10-15

Family

ID=26377318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92109374T ATE143810T1 (de) 1991-06-03 1992-06-03 Hepatozytwachstumsfaktor enthaltende mittel

Country Status (9)

Country Link
US (2) US5545722A (enExample)
EP (1) EP0517182B1 (enExample)
KR (1) KR100210698B1 (enExample)
AT (1) ATE143810T1 (enExample)
CA (1) CA2070263A1 (enExample)
DE (1) DE69214355T2 (enExample)
ES (1) ES2094848T3 (enExample)
HU (1) HUT62315A (enExample)
TW (1) TW318142B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
TW318142B (enExample) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
EP0730466A4 (en) * 1993-09-10 1999-04-14 Univ New York COMPOSITIONS AND METHOD FOR INHIBITING THE INVASION OF HEPATOCYTES BY MALARIASPOROZOITES
US6756358B2 (en) 1994-08-19 2004-06-29 Sumitomo Pharmaceuticals Co., Ltd. Therapeutic agent for cartilaginous diseases
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
AU7389496A (en) * 1995-10-05 1997-04-28 Genentech Inc. Methods and compositions for treating vascular stenosis
US6146847A (en) * 1996-11-01 2000-11-14 Genespan Corporation Stabilized transient gene expression
TW529954B (en) * 1998-10-28 2003-05-01 Sankyo Co Agent for treating abnormal bone metabolism
US7829072B2 (en) * 2000-07-14 2010-11-09 Carter Daniel C Serum albumin compositions for use in cleansing or dermatological products for skin or hair
CZ20022231A3 (cs) * 2001-06-29 2003-02-12 Sankyo Company Limited Komplex skládající se z osteoklastogenezi inhibujícího faktoru a polysacharidu
SE525461C3 (sv) 2002-11-28 2005-03-23 Prophymed Ab Ny användning av dextransulfat
TWI328614B (en) * 2002-12-23 2010-08-11 Bristol Myers Squibb Co Product quality enhancement in mammalian cell culture processes for protein production
CA2511520A1 (en) * 2002-12-23 2004-07-15 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
US20070116768A1 (en) * 2003-12-09 2007-05-24 Michael Chorny Sustained release preparations composed of biocompatible complex microparticles
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045534A (ja) * 1983-08-22 1985-03-12 Otsuka Pharmaceut Co Ltd 肝実質細胞増殖因子
EP0412577A1 (de) * 1986-05-09 1991-02-13 Hoechst Aktiengesellschaft Herbizide Mittel
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
JPH0247916A (ja) * 1988-08-08 1990-02-16 Nec Corp アナログコンパレータ
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
CA2022752C (en) * 1989-08-11 1998-07-07 Naomi Kitamura Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor
JP2784455B2 (ja) * 1990-05-09 1998-08-06 敏一 中村 肝硬変治療剤
TW318142B (enExample) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd

Also Published As

Publication number Publication date
TW318142B (enExample) 1997-10-21
ES2094848T3 (es) 1997-02-01
DE69214355T2 (de) 1997-03-06
EP0517182B1 (en) 1996-10-09
KR100210698B1 (ko) 1999-07-15
DE69214355D1 (de) 1996-11-14
US5545722A (en) 1996-08-13
HUT62315A (en) 1993-04-28
EP0517182A1 (en) 1992-12-09
CA2070263A1 (en) 1992-12-04
KR930000120A (ko) 1993-01-15
US5736506A (en) 1998-04-07
HU9201856D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
ATE143810T1 (de) Hepatozytwachstumsfaktor enthaltende mittel
ITMI931518A0 (it) Derivati eparinici ad attivita' antimetastatica
FI925892L (fi) Pulverformiga, tvaerbundna polymerer, som absorberar vattenhaltiga vaetskor och blod, foerfarande foer framstaellning av dessa och anvaendning av dessa som absorptionsmedel i sanitetsprodukter
TW239148B (enExample)
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI935110L (fi) N,N-disubstituerade arylcykloalkylaminer, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning samt foerfarande foer deras framstaellning
IT1260136B (it) Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
ES2085462T3 (es) Combinacion anticoagulante de laci y de polisacaridos sulfatados.
FI953565L (fi) Uusi antikoagulanttikofaktoriaktiivisuus
IT9041752A0 (it) Nuovi derivati dell'eparina
DE59303196D1 (de) Förderbahn, insbesondere Einschienenhängebahn
ITBO930125A0 (it) Processo per la sintesi di glicosaminoglicani semisintetici a strut- tura eparinica od eparanica modificati nella posizione 2 dell'acido d-l-iduronico-2-0-solfato.
DK247488A (da) Teicoplaninderivater
FI954876A0 (fi) Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi
FI916018A7 (fi) 1,3-dioksolaanijohdannaisia kolesterolia alentavina aineina
FI934665L (fi) Aryliden-1-azacykloalkaner och arylalkyl-1-azacyckloalkaner, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning och framstaellning
ITMI922071A0 (it) Derivati xantonici, loro preparazione ed attivita'
ITMI910393V0 (it) Fondo per cabine di verniciatura, provvisto di condotti di scarico posizionati in modo da favorire l'abbattimento delle particelle di vernice in sospensione
IT231024Y1 (it) Struttura d'arredamento componibile a montanti particolarmente per attaccapanni, lampade a stelo e tavoli
ITMI921856A0 (it) Derivati della fenetilammina aventi attivita' dopaminergica
ITMI921857A1 (it) Derivati della fenetilammina aventi attivita' dopaminergica
ITRM930801A1 (it) Portone scorrevole con uscita di sicurezza e assi di bloccaggio azionati da camme, per il bloccaggio della parte inferiore del portone e per l'irrigidimento della struttura in corrispondenza dell'uscita di sicurezza.
ITMI931719A0 (it) Derivati delle fenetilammina aventi attivita' dopaminergica
ITMI920359V0 (it) Struttura di porta,particolarmente per mobili
IT223046Z2 (it) Struttura di profilo, particolarmente per portoni industriali

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties